Announcements Trials
Browse Landscape

Phase

Phase 2 94Phase 3 25Phase NA 14Phase 1/2 8Phase 1 5Phase 4 4Phase 2/3 1

Status

Unknown 4Completed 3

Sponsor Class

OTHER 499OTHER_GOV 37INDUSTRY 35UNKNOWN 4NIH 3NETWORK 2FED 2INDIV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Lymphoid 1Gynecologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome 1Papillomavirus Infections 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Dwarfism 1Breast Neoplasms 1

Interventions

toripalimab 1Idarubicin 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Growth Hormone 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Unknown × UNKNOWN × Clear all
NCT05291910 2022-03-23

Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer

ChineseAMS

Phase 4 Unknown
70 enrolled
Breast

Breast Neoplasms

NCT01990807 2013-11-21

Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia

ChineseAMS

Phase 4 Unknown
20 enrolled
LymphoidOther hematologic neoplasm

Philadelphia Chromosome, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01901666 2013-07-17

Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission

PIMERIndia

Phase 4 Unknown
20 enrolled
MyeloidOther hematologic neoplasm

Dwarfism, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01021904 2009-11-30

Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China

ChineseAMS

Phase 4 Unknown
6,200 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡